# Broadband chiroptical sensing with two-mode subwavelength grating waveguides

Preprint · Albert A. Seredin, Roman S. Savelev

- Archive id: arxiv:2610.23630
- Published: 2026-10-16
- arXiv: https://arxiv.org/abs/2610.23630
- Citations: 0
- Source URL: https://arxiv.org/abs/2610.23630
- PDF: https://arxiv.org/pdf/2610.23630
- Provenance: arxiv

## Abstract

Engineering local optical chirality in planar photonic structures offers a route to selective and enhanced light-matter interactions with chiral media. Here, we introduce periodic dielectric waveguides that support chiral evanescent fields through the interaction of two nearly degenerate waveguide modes. We develop a perturbation theory for such a waveguide covered by a chiral layer, relating chirality-induced modal coupling and propagation-constant corrections to measurable intermodal power conversion and differential transmission. Whereas modal detuning confines the chiral response of a symmetric waveguide to a narrow spectral range, mode hybridization in an asymmetric waveguide creates individual eigenmodes that carry nonzero local chirality over a broad spectral range. We show that modal dichroism in realistic lossy waveguides can produce a significant background differential transmission signal. Such a background, however, can be suppressed by comparing transmission through two asymmetric waveguides with opposite structural asymmetries, allowing the chiral response to be reliably extracted. Together, these findings provide a basis for developing integrated photonic components with locally chiral fields, including waveguides, metasurfaces, and resonators.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Metamaterials, Nanophotonics & Integrated Photonics](https://space-kitty.com/topics/metamaterials-photonics)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.